With high levels of demand for health care, but difficulties for consumers in gaining access to it, the challenges facing India’s health-care system are not too dissimilar to those of other emerging markets. However, India has come up with its own particular ways of dealing with these common challenges. In this blog, we look at whether the solutions it has developed to tackle overwhelming patient demand can provide valuable insights for more developed markets.
India’s expenditure on health care is well below that of large Western nations such as the U.S. and UK, but has also lagged its largest emerging-market neighbor, China.
Unlike developed markets, India has a limited primary care system which poses many challenges to health-care delivery. Much like other emerging markets, it struggles with a twin-track health-care conundrum: how to fulfil both urban and rural requirements.
While rural India tackles common communicable diseases, such as diphtheria and tuberculosis (which can often be related to poor nutrition and sanitation), urban areas generally contend with lifestyle illnesses such as diabetes and heart disease. The number of diabetics in India is expected to grow from 69 million in 2015 to 123 million by 2040, a rise of 78%, according to BMI and the International Diabetes Federation.
What Can We Learn from India?
The challenge of tackling these separate issues has dictated much of India’s health-care development. There are certain health-care areas where India clearly excels, such as the ability to deliver products or services more efficiently or at a lower cost.
India is renowned for its chemical engineering expertise, and that expertise has led to a vibrant export market in the production of generic medicines. However, some of the more interesting and pioneering health-care areas in India are in service provision. Necessity is the mother of invention, and in India the focus is often on enabling doctors to perform operations more efficiently and with fewer resources. This helps to improve overall patient access, and attracts medical tourists from the surrounding region who seek affordable but high-quality health care.
With fewer primary care practitioners, there has, for example, been more focus on the development of mobile rural units that can travel to patients, and active vaccination programs which target specific diseases. India has made use of remote doctor access by employing telemedicine, which was introduced there in the late 1990s – much earlier than in more developed markets.
With limited hospital beds per head of population, the government has also been happy for private companies to take the lead in this area, and regulation has been more obliging as a result.
As we face a future where absolute spending on health care is expected to rise in almost all global markets (as the chart below shows), many of the solutions as to how to address lower-cost health-care provision more effectively may well emanate from markets such as India.
Global Health-Care Expenditure and Future Projections in USD Billions, as % of GDP
Source: BMI forecast, World Health Organization, June 29, 2017
This is a financial promotion. Material in this publication is for general information only. The opinions expressed in this document are those of Newton and should not be construed as investment advice or recommendations for any purchase or sale of any specific security or commodity. Certain information contained herein is based on outside sources believed to be reliable, but its accuracy is not guaranteed. You should consult your advisor to determine whether any particular investment strategy is appropriate. This material is for institutional investors only. Compared to more established economies, the value of investments in emerging markets may be subject to greater volatility, owing to differences in generally accepted accounting principles or from economic, political instability or less developed market practices. Any reference to a specific security, country or sector should not be construed as a recommendation to buy or sell this security, country or sector. Please note that strategy holdings and positioning are subject to change without notice.
This is a financial promotion. Issued by Newton Investment Management Limited, The Bank of New York Mellon Centre, 160 Queen Victoria Street, London, EC4V 4LA. Newton Investment Management Limited is authorized and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN and is a subsidiary of The Bank of New York Mellon Corporation. 'Newton' and/or 'Newton Investment Management' brand refers to Newton Investment Management Limited. Newton is registered in England No. 01371973. VAT registration number GB: 577 7181 95. Newton is registered with the SEC as an investment adviser under the Investment Advisers Act of 1940. Newton's investment business is described in Form ADV, Part 1 and 2, which can be obtained from the SEC.gov website or obtained upon request. Material in this publication is for general information only. The opinions expressed in this document are those of Newton and should not be construed as investment advice or recommendations for any purchase or sale of any specific security or commodity. Certain information contained herein is based on outside sources believed to be reliable, but its accuracy is not guaranteed. You should consult your advisor to determine whether any particular investment strategy is appropriate. This material is for institutional investors only.
Personnel of certain of our BNY Mellon affiliates may act as: (i) registered representatives of BNY Mellon Securities Corporation (in its capacity as a registered broker-dealer) to offer securities, (ii) officers of the Bank of New York Mellon (a New York chartered bank) to offer bank-maintained collective investment funds, and (iii) Associated Persons of BNY Mellon Securities Corporation (in its capacity as a registered investment adviser) to offer separately managed accounts managed by BNY Mellon Investment Management firms, including Newton and (iv) representatives of Newton Americas, a Division of BNY Mellon Securities Corporation, U.S. Distributor of Newton Investment Management Limited.
Unless you are notified to the contrary, the products and services mentioned are not insured by the FDIC (or by any governmental entity) and are not guaranteed by or obligations of The Bank of New York or any of its affiliates. The Bank of New York assumes no responsibility for the accuracy or completeness of the above data and disclaims all expressed or implied warranties in connection therewith. © 2020 The Bank of New York Company, Inc. All rights reserved.